- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
7 result(s) found for: Fibula.
Displaying page 1 of 1.
| EudraCT Number: 2013-000875-33 | Sponsor Protocol Number: PLATA | Start Date*: 2013-08-27 | |||||||||||
| Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
| Full Title: Prevention of Phantom Limb Pain After Transtibial Amputation (PLATA) - Randomized, double-blind, controlled, multi-center trial comparing Optimized intravenous pain control vs Optimized intravenous... | |||||||||||||
| Medical condition: Phantom limb pain following amputation of the lower leg due to critical limb ischemia. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) ES (Ongoing) AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-005667-26 | Sponsor Protocol Number: 130256 | Start Date*: 2007-07-11 | ||||||||||||||||
| Sponsor Name:Ninewells Hospital | ||||||||||||||||||
| Full Title: A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb p... | ||||||||||||||||||
| Medical condition: Pain after amputation | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-000650-38 | Sponsor Protocol Number: ALLOB-MF1 | Start Date*: 2015-07-01 | |||||||||||
| Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
| Full Title: A Phase IIA, multicentre, open study on the safety and efficacy of allogeneic osteoblastic cells (ALLOB®) implantation in multiple non-infected delayed-union (DU) fractures | |||||||||||||
| Medical condition: Multiple non-infected delayed-union fractures | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-001282-12 | Sponsor Protocol Number: NVD003-CLN02-CPT | Start Date*: 2022-08-02 |
| Sponsor Name:Novadip Biosciences | ||
| Full Title: A proof-of-concept study with NVD-003, an autologous osteogenic bone graft, in the treatment of congenital pseudarthrosis of the tibia in pediatric patients | ||
| Medical condition: congenital pseudarthrosis of the tibia (CPT) | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005333-36 | Sponsor Protocol Number: ALLOB-DU1 | Start Date*: 2013-07-30 | |||||||||||
| Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
| Full Title: A pilot Phase I/IIa, multicentre, open proof-of-concept study on the efficacy and safety of allogeneic osteoblastic cells (ALLOB®) implantation in non-infected delayed-union fractures | |||||||||||||
| Medical condition: Non-infected delayed-union fractures | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) GB (Prematurely Ended) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-001630-18 | Sponsor Protocol Number: CWL15001 | Start Date*: 2023-09-20 | |||||||||||
| Sponsor Name:5med GmbH | |||||||||||||
| Full Title: A randomized, parallel group, multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management and prolonged open treatment over up to 120 hours post... | |||||||||||||
| Medical condition: Management of pain following orthopedic surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Trial now transitioned) BG (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-002302-46 | Sponsor Protocol Number: IMIB-TCIM/ELAII-2019-01 | Start Date*: 2019-10-23 |
| Sponsor Name:Fundación para la Formación e Investigación Sanitarias de la Región de Murcia | ||
| Full Title: Phase II clinical trial of intramuscular infusion of autologous bone marrow stem cells in patients with amyotrophic lateral sclerosis | ||
| Medical condition: Amyotrophic Lateral Sclerosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.